Condition
Ovarian Stimulation clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Ovarian Stimulation clinical trials that are recruiting, at sites in 3 countries (most in United Arab Emirates (3), Belgium (1), Spain (1)). By phase: Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 3Countries
Newest Ovarian Stimulation clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| AI-guided trigger timing to optimize egg retrieval in IVF | — | Sabadell, Barcelona and 4 other locations | Recruiting | Apr 7, 2026 |
| Measuring follicular volume to improve oocyte maturation in women with low ovarian reserve | — | Abu Dhabi, Abu Dhabi Emirate | Recruiting | Feb 21, 2025 |
| rFSH versus hMG effects on cumulus cell telomere length and blastocyst development | — | Abu Dhabi, Abu Dhabi Emirate | Recruiting | Dec 13, 2024 |
| Monitoring FSH levels to optimize ovarian stimulation | — | Abu Dhabi, Abu Dhabi Emirate | Recruiting | Aug 27, 2024 |
| Progestin-primed ovarian stimulation with corifollitropin alfa versus standard rFSH/GnRH antagonist (crossover) | Phase 4 | Ghent | Recruiting | Dec 19, 2023 |
All recruiting trials (5)
-
AI-guided trigger timing to optimize egg retrieval in IVF
This trial tests whether an AI program can guide monitoring and the ovulation trigger to produce similar or better IVF cycle results than decisions made by doctors.
-
Measuring follicular volume to improve oocyte maturation in women with low ovarian reserve
This study is testing if measuring the size of ovarian follicles can help women with low egg supply get healthier eggs during fertility treatment.
-
rFSH versus hMG effects on cumulus cell telomere length and blastocyst development
This trial will test whether using recombinant FSH (Gonal‑F) versus human menopausal gonadotropin (Menopur) during ovarian stimulation changes cumulus cell telomere length and later blastocyst outcomes in women 18–38 undergoing IVF with PGT‑A.
-
Monitoring FSH levels to optimize ovarian stimulation
This study is testing if keeping track of FSH hormone levels can help improve the success of ovarian stimulation for women trying to conceive.
-
Progestin-primed ovarian stimulation with corifollitropin alfa versus standard rFSH/GnRH antagonist (crossover)
This study will test whether progestin-primed ovarian stimulation using a single-dose corifollitropin alfa improves patient satisfaction and compliance while producing similar ovarian response compared with conventional recombinant FSH plus a GnRH antagonist in women having their first IVF/ICSI cycle for fertility pres
Related topics
Quick answers
How many Ovarian Stimulation clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United Arab Emirates (3 trials), Belgium (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.